The summer of 2023 will not be remembered as one that was kind to equity traders. Over the course of the last month alone, all major stock indices in the US like AMEX:SPY NASDAQ:QQQ and DJ:DJI closed in the red as investor sentiment wavered in the face sky-high interest rates, growing consumer debt, an economic slowdown in China, and overall low summertime...
The summer of 2023 will not be remembered as one that was kind to equity traders. Over the course of the last month alone, all major stock indices in the US like AMEX:SPY NASDAQ:QQQ and DJ:DJI closed in the red as investor sentiment wavered in the face sky-high interest rates, growing consumer debt, an economic slowdown in China, and overall low summertime...
In the dynamic world of pharmaceutical investments, DR. REDDY'S Laboratories (NSE: DRREDDY) (NYSE: RDY) stands out as a notable performer, surpassing Jazz Pharmaceuticals plc (JAZZ), Sarepta Therapeutics, Inc. (SRPT), and the iShares U.S. Pharmaceuticals (IHE) and SPDR S&P Pharmaceuticals (XPH) ETF’s,
In terms of background, DR. REDDY'S Laboratories Ltd. (NSE:...
Despite the market's emergent rally in July, 2022 has been a punishing year for tech equities worldwide. Recent Q2 earning from megacap tech players in the US deepen concerns about diminishing margins and slowed hiring moving into Q3/4 and beyond. YTD, Nasdaq is down -21%, and unerperformed the DOW, S&P500, and Russell2000.
One sector with more bullish...
